pentobarbital will decrease the level or influence of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use of alternative treatment options is strongly encouraged when linagliptin should be to be administered with a CYP3A4 inducerpentobarbital will minimize the level or influence of dapsone by impacting hep